Literature DB >> 15596833

Dendritic cells and macrophages are productively infected by poliovirus.

Rahnuma Wahid1, Martin J Cannon, Marie Chow.   

Abstract

Expression of the poliovirus receptor (PVR) on cells is a major host determinant of infection by poliovirus. Previously, the only immune cell type known to express PVR was the blood-derived monocyte, which is susceptible to infection at very low frequency. We demonstrate that professional antigen-presenting cells-macrophages and dendritic cells, generated upon differentiation of monocytes-retain expression of PVR and are highly susceptible to infection by type 1 Mahoney strain of poliovirus. Maximal cell-associated titers of virus are obtained within 6 to 8 h postinfection, and cell death and lysis occurs within 24 h postinfection. Similar kinetics are observed in cells infected with the Sabin 1 vaccine strain. Although protein synthesis and receptor-mediated endocytosis are inhibited upon poliovirus infection of these critical antigen-presenting cells, we demonstrate for the first time that functional presentation of antigen occurs in these infected cells via the HLA class II pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15596833      PMCID: PMC538697          DOI: 10.1128/JVI.79.1.401-409.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

Authors:  A Rodriguez; A Regnault; M Kleijmeer; P Ricciardi-Castagnoli; S Amigorena
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

3.  Competing death programs in poliovirus-infected cells: commitment switch in the middle of the infectious cycle.

Authors:  V I Agol; G A Belov; K Bienz; D Egger; M S Kolesnikova; L I Romanova; L V Sladkova; E A Tolskaya
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

Review 4.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

5.  Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y.

Authors:  N La Monica; V R Racaniello
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Poliovirus induces apoptosis in the human U937 promonocytic cell line.

Authors:  J A López-Guerrero; M Alonso; F Martín-Belmonte; L Carrasco
Journal:  Virology       Date:  2000-07-05       Impact factor: 3.616

7.  Polyethylene glycol-modified GM-CSF expands CD11b(high)CD11c(high) but notCD11b(low)CD11c(high) murine dendritic cells in vivo: a comparative analysis with Flt3 ligand.

Authors:  E Daro; B Pulendran; K Brasel; M Teepe; D Pettit; D H Lynch; D Vremec; L Robb; K Shortman; H J McKenna; C R Maliszewski; E Maraskovsky
Journal:  J Immunol       Date:  2000-07-01       Impact factor: 5.422

8.  Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans.

Authors:  J Simons; M Kutubuddin; M Chow
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.

Authors:  K Inaba; S Turley; T Iyoda; F Yamaide; S Shimoyama; C Reis e Sousa; R N Germain; I Mellman; R M Steinman
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

10.  Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence.

Authors:  M Gromeier; B Bossert; M Arita; A Nomoto; E Wimmer
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more
  33 in total

1.  Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Recombinant poliovirus for cancer immunotherapy.

Authors:  Millena Prata Jammal; Márcia Antoniazi Michelin; Rosekeila Simões Nomelini; Eddie Fernando Candido Murta
Journal:  Ann Transl Med       Date:  2018-09

Review 3.  Oncolytic immunotherapy through tumor-specific translation and cytotoxicity of poliovirus.

Authors:  Michael C Brown; Matthias Gromeier
Journal:  Discov Med       Date:  2015-05       Impact factor: 2.970

Review 4.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

Review 5.  Oncolytic polio virotherapy of cancer.

Authors:  Michael C Brown; Elena Y Dobrikova; Mikhail I Dobrikov; Ross W Walton; Sarah L Gemberling; Smita K Nair; Annick Desjardins; John H Sampson; Henry S Friedman; Allan H Friedman; Douglas S Tyler; Darell D Bigner; Matthias Gromeier
Journal:  Cancer       Date:  2014-06-17       Impact factor: 6.860

6.  A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function.

Authors:  Subhashini Arimilli; Martha A Alexander-Miller; Griffith D Parks
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function.

Authors:  Subhashini Arimilli; John B Johnson; Kimberly M Clark; Aaron H Graff; Martha A Alexander-Miller; Steven B Mizel; Griffith D Parks
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

8.  Poliovirus induces Bax-dependent cell death mediated by c-Jun NH2-terminal kinase.

Authors:  Arnaud Autret; Sandra Martin-Latil; Laurence Mousson; Aurélie Wirotius; Frédéric Petit; Damien Arnoult; Florence Colbère-Garapin; Jérôme Estaquier; Bruno Blondel
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

9.  TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways.

Authors:  Subhashini Arimilli; John B Johnson; Martha A Alexander-Miller; Griffith D Parks
Journal:  Virology       Date:  2007-04-24       Impact factor: 3.616

10.  Early phosphatidylinositol 3-kinase/Akt pathway activation limits poliovirus-induced JNK-mediated cell death.

Authors:  Arnaud Autret; Sandra Martin-Latil; Cynthia Brisac; Laurence Mousson; Florence Colbère-Garapin; Bruno Blondel
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.